Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

Share Price is delayed by 15 minutes
Get Live Data
460.00    -44.00 (-8.73%)
Bid:
479.00
Ask:
499.00
Spread: 20.00 (4.175%)
Market Cap: £181.77m
VP. Live PriceLast checked at - London Stock Exchange

Intraday Vp Share Chart

Form 8 (OPD) - Vp PLC

12 May 2022 12:55

RNS Number : 3125L
Vp PLC
12 May 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Vibroplant Trustees Limited (as nominee for the Vp Employee Trust)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Vp Employee Trust

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vp plc

(d) Is the discloser the offeror or the offeree?

N/A

(e) Date position held:

The latest practicable date prior to the disclosure

12 May 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 5p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

499,774

1.24%

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

499,774

1.24%

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

12 May 2022

Contact name:

Allison Bainbridge, Group Finance Director

Telephone number:

+44 (0)1423 533 445

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGPUWAAUPPGGP
Date   Source Headline
18th Jun 20262:05 pmRNSDirector Declaration
10th Jun 20267:00 amRNSFinal Results
29th May 20267:00 amRNSNotice of Results & Investor Presentation
17th Apr 20267:00 amRNSTrading Update
30th Mar 20263:15 pmRNSDirector Share Purchase
19th Mar 20267:00 amRNSDirector Share Purchase
3rd Mar 20263:30 pmRNSDirector Share Purchase
11th Feb 20267:00 amRNSTrading Update
2nd Feb 20267:00 amRNSCEO Transition Update
19th Dec 20257:00 amRNSCEO Appointment
19th Dec 20257:00 amRNSCEO Appointment
27th Nov 20257:00 amRNSInterim Results
17th Oct 20257:00 amRNSNotice of Results & Investor Presentation
10th Oct 20257:00 amRNSTrading Update
24th Sep 20257:00 amRNSCEO succession
1st Aug 202511:00 amRNSNotification of Major Holdings
30th Jul 20254:45 pmRNSGrant of SAYE Options and PDMR Dealing
23rd Jul 20253:00 pmRNSResults of Annual General Meeting
23rd Jul 20257:00 amRNSAGM Statement
21st Jul 20255:17 pmRNSGrant of Long Term Incentive Plan Awards
21st Jul 20255:16 pmRNSGrant of Long Term Incentive Plan Awards
21st Jul 20255:15 pmRNSGrant of Long Term Incentive Plan Awards
30th Jun 20257:00 amRNSDirectorate Change
24th Jun 20252:30 pmRNSAnnual Report and Notice of AGM
11th Jun 20257:00 amRNSFinal Results
9th Jun 20253:00 pmRNSPCA Dealing
27th May 20257:00 amRNSNotice of Results & Investor Presentation
15th Apr 20257:00 amRNSTrading Update
27th Mar 20259:00 amRNSDirector Declaration
6th Feb 20252:31 pmRNSDirector Share Purchase
6th Feb 20252:30 pmRNSDirector Share Purchase
30th Jan 20257:00 amRNSAppointment of Non-Executive Director
29th Jan 20254:00 pmRNSDirector Share Purchase
29th Jan 20254:00 pmRNSDirector Share Purchase
23rd Jan 202512:00 pmRNSDirector Share Purchase
22nd Jan 202512:00 pmRNSDirector Share Purchase
17th Jan 20251:45 pmRNSDirector Share Purchase
9th Jan 20253:00 pmRNSAnnex DTR3
26th Nov 20247:00 amRNSInterim Results
30th Oct 20247:00 amRNSNotice of Results & Investor Presentations
3rd Oct 20247:01 amRNSTrading Update
3rd Oct 20247:00 amRNSAcquisition of Charleville Hire and Platform Ltd
13th Aug 20244:17 pmRNSDirector/PDMR Shareholding
8th Aug 20241:06 pmRNSDirector/PDMR Shareholding
25th Jul 20243:09 pmRNSResults of Annual General Meeting
25th Jul 20247:00 amRNSAGM Statement
24th Jul 20242:27 pmRNSPDMR Dealings
24th Jul 20242:25 pmRNSPDMR Dealings
24th Jul 20242:23 pmRNSPDMR Dealings
11th Jul 20242:38 pmRNSAnnex DTR3

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.